glp-1 makers Sauce, spice attract deal interest as GLP-1s send Americans looking for hot stuff Insulin pump-makers grapple with questions
Description
Novo Nordisk A/S Pfizer, Inc
This may suggest off-label prescribing of GLP-1s approved for T2D when GLP-1s approved for overweight and obesity are unavailable
Epub 2023/01/25
Many people need to use them long term, combined with lifestyle changes, to keep the weight off.
True migraines, the kind with throbbing pain and neurological symptoms, were much less common
Plus a non-obese mast cell patient, who, due to a pharmacy error, got 2.0mg instead of .75mg, improved further.) The just-announced 1,000-person Scripps LOCIT trial for long COVID is using the same dose
